Tagrisso Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

TAGRISSO 40 mg tablets: Beige, 9 mm, round, biconvex tablet, debossed with "AZ" and "40" on one side and plain on the reverse.
Each tablet contains 40 mg osimertinib (as mesylate).
TAGRISSO 80 mg tablets: Beige, 7.25 x 14.5 mm, oval, biconvex tablet, debossed with "AZ" and "80" on one side and plain on the reverse.
Each tablet contains 80 mg osimertinib (as mesylate).
Excipients/Inactive Ingredients: Tablet core: Mannitol, Microcrystalline cellulose, Low-substituted hydroxypropyl cellulose, Sodium stearyl fumarate.
Tablet coating: Polyvinyl alcohol, Titanium dioxide (E 171), Macrogol 3350, Talc, Yellow iron oxide (E 172), Red iron oxide (E 172), Black iron oxide (E 172).

Manufacturer:

AstraZeneca

Distributor:

Zuellig Pharma